Skip to content

Fluorescence optical imaging in patients with juvenile rheumatic diseases

Fluorescence optical imaging in patients with juvenile rheumatic diseases

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00012572
Enrollment
100
Registered
2017-07-31
Start date
2013-10-14
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

M08 M25.5

Interventions

Group 1: This study prospectively assessed the diagnostic validity of fluorescence optical imaging for assessing inflammation in hand and finger joints of children with and without inflammatory rheuma

Sponsors

Vivantes Klinikum im FriedrichshainKlinik für Kinder- und Jugendmedizin
Lead Sponsor

Eligibility

Sex/Gender
All
Age
6 Years to 18 Years

Inclusion criteria

Inclusion criteria: - Children and adolescents aged 6 to 18 years affected by an inflammatory rheumatic disease (i.e., juvenile idiopathic arthritis [JIA]) or a non-inflammatory rheumatic disease (i.e., pain syndromes) affecting the hands and fingers - Consent to participate in Xiralite® examination

Exclusion criteria

Exclusion criteria: - allergy against ICG or iodine or Gadolinium - hyperthyroidism - pregnancy and breast feeding - other known severe diseases - chronic or active infection of the hands

Design outcomes

Primary

MeasureTime frame
Detection of inflammation in wrist and finger joints by clinical examination, sonographic examination and fluorescence optical imaging.

Secondary

MeasureTime frame
Qualitative and quantitative assessment of fluorescence optical imaging findings in children and adolescents with inflammatory and non-inflammatory joint diseases

Countries

Germany

Contacts

Public ContactHermann Girschick

Vivantes Klinikum im Friedrichshain

Hermann.Girschick@vivantes.de0049 30 130 23-1572

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Mar 8, 2026